Product Overview
BEYFORTUS is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease
Product Features
- BEYFORTUS is an antibody that contains nirsevimab-alip which is used to help prevent RSV disease for 5 months
- Indicated for Newborns and babies under 1 year of age born during or entering their first RSV season, and children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season
- For Intramuscular Injection Only
Product Specifications
| Catalog Number/SKU | MF-49281057515 |
| Application | Respiratory Syncytial Virus Vaccine |
| Container Type | Prefilled Syringe |
| Dosage Form | Injection |
| Generic Drug Code | 54466 |
| Generic Drug Name | Nirsevimab-alip |
| NDC Number | 49281057515 |
| Storage Requirement | Requires Refrigeration |
| Strength | 50mg/0.5ml |
| Type | Intramuscular |
| UNSPSC Code | 51201600 |
| User | Indicated for People from Birth Through 24 Months of Age |
| Volume | 0.5 ml |
